- Home
- ICAD vs CCCC Comparison
ICAD vs CCCC Comparison
Compare ICAD & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- CCCC
- Stock Information
- Founded
- ICAD 1984
- CCCC 2015
- Country
- ICAD United States
- CCCC United States
- Employees
- ICAD N/A
- CCCC N/A
- Industry
- ICAD Medical/Dental Instruments
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- CCCC Health Care
- Exchange
- ICAD Nasdaq
- CCCC Nasdaq
- Market Cap
- ICAD 103.3M
- CCCC 104.4M
- IPO Year
- ICAD 1986
- CCCC 2020
- Fundamental
- Price
- ICAD $3.69
- CCCC $1.50
- Analyst Decision
- ICAD Hold
- CCCC Buy
- Analyst Count
- ICAD 1
- CCCC 3
- Target Price
- ICAD N/A
- CCCC $12.00
- AVG Volume (30 Days)
- ICAD 300.2K
- CCCC 1.0M
- Earning Date
- ICAD 08-12-2025
- CCCC 07-31-2025
- Dividend Yield
- ICAD N/A
- CCCC N/A
- EPS Growth
- ICAD N/A
- CCCC N/A
- EPS
- ICAD N/A
- CCCC N/A
- Revenue
- ICAD $19,528,000.00
- CCCC $39,783,000.00
- Revenue This Year
- ICAD $3.60
- CCCC N/A
- Revenue Next Year
- ICAD N/A
- CCCC N/A
- P/E Ratio
- ICAD N/A
- CCCC N/A
- Revenue Growth
- ICAD 8.86
- CCCC 98.56
- 52 Week Low
- ICAD $1.18
- CCCC $1.09
- 52 Week High
- ICAD $4.02
- CCCC $7.66
- Technical
- Relative Strength Index (RSI)
- ICAD 50.46
- CCCC 50.55
- Support Level
- ICAD $3.58
- CCCC $1.36
- Resistance Level
- ICAD $3.88
- CCCC $1.63
- Average True Range (ATR)
- ICAD 0.12
- CCCC 0.14
- MACD
- ICAD -0.04
- CCCC -0.00
- Stochastic Oscillator
- ICAD 33.33
- CCCC 38.33
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.